五养堂药业品牌怎么样 申请店铺

我要投票 五养堂药业在灵芝孢子粉行业中的票数:8 更新时间:2024-11-22
五养堂药业是哪个国家的品牌?「五养堂药业」是 浙江五养堂药业有限公司 旗下著名品牌。该品牌发源于浙江省丽水市,由创始人吴 * 谦在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
五养堂药业怎么样

浙江五养堂药业有限公司使命是弘扬中医药五行养生文化,以现代生物科技制造灵芝、三叶青、铁皮石斛和红曲等道地药材的趁鲜口型中药饮片、保健食品、中药养生食品,以振兴中药保健食品产业和推动中药食疗食养、促进人类健康为己任,创新发展养肝(保肝明目)、养心(安心养神)、养脾(健脾益胃)、养肺(润肺养颜)、养肾(补肾益精)的五养系列健康产品,打造具有民族特色的中药保健养生和健康服务品牌。

浙江五养堂药业有限公司成立于2004年1月,其前身是浙江益圣菌物发展有限公司,由浙江省林业科学研究院、丽水市食用菌研究开发中心和吴学谦教授等40名自然人共同发起组建。2013年经严格的评估和公开挂牌交易,浙江省林业科学研究院的股份由吴学良等股东受让持有,国有股份全部退出,正式更名为“浙江五养堂药业有限公司”。

公司厂区占地面积20亩,建筑面积16000多平方米,建有中药饮片GMP车间、保健食品GMP车间、生物发酵车间、趁鲜冷冻超微破壁车间等四大健康产品生产线,目前是浙江省较大的灵芝破壁孢子粉、真菌多糖提取加工和三叶青口服型中药饮片趁鲜冷冻加工基地,产品远销欧美、日本、香港、台湾等国家和地区。

五养堂选育成功了“浙青1号“等新品种、掌握了三叶青的核心种植技术,已经申请了“一种果林地仿生套种袋式三叶青方法”等8项专利,通过三叶青趁鲜口服型加工技术改造和研发三叶青保健食品与抗菌抗炎退烧药品,拟从一产(规范种植)+二产(药品、保健食品加工)+三产(线上线下营销服务、健康服务、健康管理、健康保险、供应链管理)全产业链运作,将这一“天然的植物抗生素”三叶青产业做强做大。

五养堂将于2016年在新三板系统挂牌,并争取在1-2年内进入创新层,通过联合上市大企业搞定向增发,借助资本市场的力量将五养堂健康产业做强做大,实现百亿规模的企业梦想,并力求将五行中医药养生文化结合中国特色健康产品走向全世界。


The mission of Zhejiang wuyangtang Pharmaceutical Co., Ltd. is to carry forward the five elements health preservation culture of traditional Chinese medicine, to produce fresh Chinese herbal pieces, health food and health food of traditional Chinese medicine, such as Ganoderma lucidum, Trifolium, Dendrobium candidum and Monascus, with modern biotechnology, to revitalize the industry of health food of traditional Chinese medicine, promote the diet and nutrition of traditional Chinese medicine, and promote human health as its own duty, and innovate and develop the liver (liver protection Five series of health products, i.e. Mingmu, Yangxin (peace of mind and mind), yangpi (invigorating the spleen and stomach), Yangfei (moistening the lungs and beautifying the face) and Yangshen (invigorating the kidney and benefiting the essence), will build a brand of traditional Chinese medicine health care and health service with national characteristics. Zhejiang wuyangtang Pharmaceutical Co., Ltd. was founded in January 2004. Its predecessor is Zhejiang Yisheng fungus development Co., Ltd. which was jointly initiated and established by 40 natural persons including Zhejiang Academy of Forestry Sciences, Lishui edible fungus research and development center and Professor Wu Xueqian. In 2013, after strict evaluation and public listing, the shares of Zhejiang Academy of Forestry Sciences were transferred and held by Wu Xueliang and other shareholders, and all state-owned shares were withdrawn, officially renamed as "Zhejiang wuyangtang Pharmaceutical Co., Ltd.". The factory area of the company covers an area of 20 mu, with a building area of more than 16000 square meters. It has four major production lines for healthy products, including GMP workshop for Chinese herbal pieces, GMP workshop for health food, biological fermentation workshop, ultra-fine wall breaking workshop for fresh freezing. At present, it is a large base for the extraction and processing of Ganoderma lucidum wall breaking spore powder, fungal polysaccharide and Sanyeqing oral Chinese herbal pieces while fresh freezing in Zhejiang Province. The products are sold far Europe, America, Japan, Hong Kong, Taiwan and other countries and regions. Wuyangtang has successfully selected new varieties such as "zheqing No.1" and mastered the core planting technology of sanyeqin. It has applied for eight patents such as "a bionic interplanting bag type of sanyeqin in fruit forest". Through the technological transformation of sanyeqin taking advantage of the fresh oral processing technology and the research and development of sanyeqin health food and anti-bacterial, anti-inflammatory and fever reducing drugs, it is planned to produce from the first (standard planting) + the second (medicine, health food) Product processing) + three industries (online and offline marketing services, health services, health management, health insurance, supply chain management) operate in the whole industrial chain, making this "natural plant antibiotic" three leaf green industry stronger and bigger. Wuyangtang will be listed in the new three board system in 2016, and strive to enter the innovation layer within 1-2 years. Through joint listing of large enterprises to conduct targeted additional issuance, with the help of capital market, wuyangtang health industry will be stronger and bigger, and realize the enterprise dream of 10 billion scale, and strive to integrate the five elements of traditional Chinese medicine health culture with Chinese characteristics of health products to the world.

本文链接: https://brand.waitui.com/b6e82ab79.html 联系电话:0578-2959008,2958959

千城特选小程序码

7×24h 快讯

核聚变产业受青睐,多家公司早已涉足

近期,国务院国资委在署名文章中提出超前布局梯次培育量子科技、核聚变、生物制造、6G等未来产业,再次点燃市场对核聚变产业的热情。11月20日,上海未来聚变能源科技有限公司成立,从股东结构来看,其背后有上海电气控股集团有限公司等3家上海国资旗下公司力挺。环顾A股市场,多家上市公司已从产业链不同领域涉足核聚变赛道。昨日,不少投资者在互动平台密集追问旭光电子、合锻智能等上市公司在核聚变领域的技术、产品、项目等最新进展。(上证报)

51分钟前

服装零售商Gap上调全年业绩预期

据报道,服装零售商Gap上调了全年业绩预期,预计本财年销售额将增长1.5%至2%,而此前的预测是增长不到1%,同时上调的还有毛利率和营业收入预测。公司首席执行官理查德·迪克森在接受采访时表示,“从根本上讲,我们的业务比去年要好。”他补充说,该公司的品牌正在“跨类别”抢占市场份额。(界面)

51分钟前

“谈生意不再藏着掖着”,期现融合推动化工产业链共赢

在化工贸易环节,上游想把价格卖在高位,下游想把价格买在低位,这种情况长期存在。但随着期货工具的引入,贸易商发挥期现综合服务优势,使用基差贸易等新型模式推动产业链从“对立”走向“共赢”。贸易环节实现深度期现融合,是近年来化工产业的一大变化。近年来,受产能投放周期等因素影响,化工品价格波动幅度较大,产业链企业加工利润被显著压缩。这种情况下,头部贸易商运用期货和衍生品工具带动行业合作共赢,在保障产业链供应链安全稳定方面发挥了积极作用。(上证报)

51分钟前

中信建投:低碳环保政策持续完善,全面推进资源循环利用

36氪获悉,中信建投研报称,近期,工信部部长金壮龙发表《进一步全面深化工业和信息化领域改革为推进新型工业化注入强大动力》,提出做强绿色制造业,发展绿色低碳产业,完善绿色环保、新能源装备等发展政策。

51分钟前

临近年底,A股易主暗流涌动

临近岁末,A股控制权交易市场暗流涌动。直观来看,“易主”案例近期密集浮现。据不完全统计,10月以来,已有18家上市公司披露交易性控制权变动事项(剔除国资无偿划转、家族内部划转等)。其中,基本面向下、现金流趋紧的公司占据多数,不少公司或面临“戴帽”或“保壳”的压力。水面之下,此前几近沉寂的壳交易,已有买方在摩拳擦掌。多位投行人士反映,近期来咨询买壳事宜的人明显多了起来。(上证报)

51分钟前

本页详细列出关于林中宝的品牌信息,含品牌所属公司介绍,林中宝所处行业的品牌地位及优势。
咨询